Inflammatory Bowel Disease Market Report

Global and Region Inflammatory Bowel Disease Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：210
  • REPORT CODE：GMM926368
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Inflammatory Bowel Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Inflammatory Bowel Diseasemarket, defines the market attractiveness level of Inflammatory Bowel Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Inflammatory Bowel Disease industry, describes the types of Inflammatory Bowel Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inflammatory Bowel Disease market and the development prospects and opportunities of Inflammatory Bowel Disease industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inflammatory Bowel Disease market in Chapter 13.

    By Player:

    • Ferring Pharmaceuticals

    • ChemoCentryx

    • UCB

    • Novo Nordisk

    • Salix Pharmaceuticals

    • Boehringer Ingelheim

    • UCB & Company

    • Abbott Laboratories

    • Galapagos

    • Biogen Idec

    • Merck & Company

    • Mitsubishi Tanabe

    • Janssen Pharmaceuticals

    • Novartis

    • Pfizer

    • Akebia Therapeutics

    • Merck

    • Celltrion

    • Genentech

    • Amgen

    • Abbvie

    By Type:

    • 5-ASA

    • Antibiotics

    • Immunomodulators

    • Other

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Inflammatory Bowel Disease Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Inflammatory Bowel Disease Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Inflammatory Bowel Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Inflammatory Bowel Disease Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Inflammatory Bowel Disease Market Analysis and Outlook to 2022

    • 7.1 Global Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.2 United States Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.3 Europe Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.4 China Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.5 Japan Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.6 India Inflammatory Bowel Disease Consumption (2017-2022)

    • 7.7 South Korea Inflammatory Bowel Disease Consumption (2017-2022)

    8 Region and Country-wise Inflammatory Bowel Disease Market Analysis and Outlook to 2028

    • 8.1 Global Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.2 United States Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.3 Europe Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.4 China Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.5 Japan Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.6 India Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    • 8.7 South Korea Inflammatory Bowel Disease Consumption Forecast (2022-2028)

    9 Global Inflammatory Bowel Disease Market Outlook by Types and Applications to 2022

    • 9.1 Global Inflammatory Bowel Disease Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5-ASA Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antibiotics Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunomodulators Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Inflammatory Bowel Disease Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Inflammatory Bowel Disease Market Outlook by Types and Applications to 2028

    • 10.1 Global Inflammatory Bowel Disease Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 5-ASA Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Inflammatory Bowel Disease Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Inflammatory Bowel Disease Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Inflammatory Bowel Disease Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Inflammatory Bowel Disease Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Inflammatory Bowel Disease Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Inflammatory Bowel Disease Market Competitive Analysis

    • 14.1 Ferring Pharmaceuticals

      • 14.1.1 Ferring Pharmaceuticals Company Details

      • 14.1.2 Ferring Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ferring Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • 14.2 ChemoCentryx

      • 14.2.1 ChemoCentryx Company Details

      • 14.2.2 ChemoCentryx Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ChemoCentryx Inflammatory Bowel Disease Product and Service

    • 14.3 UCB

      • 14.3.1 UCB Company Details

      • 14.3.2 UCB Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 UCB Inflammatory Bowel Disease Product and Service

    • 14.4 Novo Nordisk

      • 14.4.1 Novo Nordisk Company Details

      • 14.4.2 Novo Nordisk Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novo Nordisk Inflammatory Bowel Disease Product and Service

    • 14.5 Salix Pharmaceuticals

      • 14.5.1 Salix Pharmaceuticals Company Details

      • 14.5.2 Salix Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Salix Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • 14.6 Boehringer Ingelheim

      • 14.6.1 Boehringer Ingelheim Company Details

      • 14.6.2 Boehringer Ingelheim Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Boehringer Ingelheim Inflammatory Bowel Disease Product and Service

    • 14.7 UCB & Company

      • 14.7.1 UCB & Company Company Details

      • 14.7.2 UCB & Company Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 UCB & Company Inflammatory Bowel Disease Product and Service

    • 14.8 Abbott Laboratories

      • 14.8.1 Abbott Laboratories Company Details

      • 14.8.2 Abbott Laboratories Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abbott Laboratories Inflammatory Bowel Disease Product and Service

    • 14.9 Galapagos

      • 14.9.1 Galapagos Company Details

      • 14.9.2 Galapagos Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Galapagos Inflammatory Bowel Disease Product and Service

    • 14.10 Biogen Idec

      • 14.10.1 Biogen Idec Company Details

      • 14.10.2 Biogen Idec Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Biogen Idec Inflammatory Bowel Disease Product and Service

    • 14.11 Merck & Company

      • 14.11.1 Merck & Company Company Details

      • 14.11.2 Merck & Company Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Merck & Company Inflammatory Bowel Disease Product and Service

    • 14.12 Mitsubishi Tanabe

      • 14.12.1 Mitsubishi Tanabe Company Details

      • 14.12.2 Mitsubishi Tanabe Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Mitsubishi Tanabe Inflammatory Bowel Disease Product and Service

    • 14.13 Janssen Pharmaceuticals

      • 14.13.1 Janssen Pharmaceuticals Company Details

      • 14.13.2 Janssen Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • 14.14 Novartis

      • 14.14.1 Novartis Company Details

      • 14.14.2 Novartis Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Novartis Inflammatory Bowel Disease Product and Service

    • 14.15 Pfizer

      • 14.15.1 Pfizer Company Details

      • 14.15.2 Pfizer Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfizer Inflammatory Bowel Disease Product and Service

    • 14.16 Akebia Therapeutics

      • 14.16.1 Akebia Therapeutics Company Details

      • 14.16.2 Akebia Therapeutics Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Akebia Therapeutics Inflammatory Bowel Disease Product and Service

    • 14.17 Merck

      • 14.17.1 Merck Company Details

      • 14.17.2 Merck Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Merck Inflammatory Bowel Disease Product and Service

    • 14.18 Celltrion

      • 14.18.1 Celltrion Company Details

      • 14.18.2 Celltrion Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Celltrion Inflammatory Bowel Disease Product and Service

    • 14.19 Genentech

      • 14.19.1 Genentech Company Details

      • 14.19.2 Genentech Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Genentech Inflammatory Bowel Disease Product and Service

    • 14.20 Amgen

      • 14.20.1 Amgen Company Details

      • 14.20.2 Amgen Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Amgen Inflammatory Bowel Disease Product and Service

    • 14.21 Abbvie

      • 14.21.1 Abbvie Company Details

      • 14.21.2 Abbvie Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Abbvie Inflammatory Bowel Disease Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Inflammatory Bowel Disease

    • Figure Inflammatory Bowel Disease Picture

    • Table Global Inflammatory Bowel Disease Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inflammatory Bowel Disease Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inflammatory Bowel Disease Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Inflammatory Bowel Disease Consumption by Country (2017-2022)

    • Figure United States Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Table Europe Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Figure China Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Figure Japan Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Figure India Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Figure South Korea Inflammatory Bowel Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Inflammatory Bowel Disease Consumption Forecast by Country (2022-2028)

    • Figure United States Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Inflammatory Bowel Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 5-ASA Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotics Consumption and Growth Rate (2017-2022)

    • Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global 5-ASA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Inflammatory Bowel Disease Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Inflammatory Bowel Disease Export by Region (Top 5 Countries) (2017-2028)

    • Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ferring Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • Table ChemoCentryx (Foundation Year, Company Profile and etc.)

    • Table ChemoCentryx Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChemoCentryx Inflammatory Bowel Disease Product and Service

    • Table UCB (Foundation Year, Company Profile and etc.)

    • Table UCB Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB Inflammatory Bowel Disease Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Inflammatory Bowel Disease Product and Service

    • Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Inflammatory Bowel Disease Product and Service

    • Table UCB & Company (Foundation Year, Company Profile and etc.)

    • Table UCB & Company Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB & Company Inflammatory Bowel Disease Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Inflammatory Bowel Disease Product and Service

    • Table Galapagos (Foundation Year, Company Profile and etc.)

    • Table Galapagos Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galapagos Inflammatory Bowel Disease Product and Service

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Inflammatory Bowel Disease Product and Service

    • Table Merck & Company (Foundation Year, Company Profile and etc.)

    • Table Merck & Company Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Company Inflammatory Bowel Disease Product and Service

    • Table Mitsubishi Tanabe (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Inflammatory Bowel Disease Product and Service

    • Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Inflammatory Bowel Disease Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Inflammatory Bowel Disease Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inflammatory Bowel Disease Product and Service

    • Table Akebia Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Akebia Therapeutics Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akebia Therapeutics Inflammatory Bowel Disease Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Inflammatory Bowel Disease Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Inflammatory Bowel Disease Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inflammatory Bowel Disease Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inflammatory Bowel Disease Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Inflammatory Bowel Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Inflammatory Bowel Disease Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US